April 13, 2023
Protected: Nephron FDA KOL Call on CRC Liquid Biopsy Tests – Apr. 12th – REPLAY
April 6, 2023
Protected: Nephron NGS industry KOL Discussion – Apr. 5th – REPLAY
March 21, 2023
340B Pharmacy Tailwind/Manufacturer Headwind Poised to Reverse in 2H 2023
March 6, 2023
Protected: Generic Market Dynamics Expert Call – Mar. 3rd – REPLAY
February 25, 2023
Comprehensive Market Update – CRO Industry 2023
February 17, 2023
Protected: Nephron MA Innovation Series: René Lerer – CEO Longevity Health Plan – Feb. 15th – REPLAY
February 14, 2023
MedTech Matchmaker – 5 Deal Ideas for 2023
February 9, 2023
Nephron Research Ranked #1 By Institutional Investor
February 7, 2023
Next Big Things: Why Pulsed Field Ablation Will Revolutionize the Treatment of AF
February 7, 2023
Protected: Understanding the PFA Competitive Landscape – Feb. 7th – REPLAY
February 3, 2023
Protected: Nephron Expert Call: Humira Biosimilar Launch Dynamics – Feb. 3rd – REPLAY
January 20, 2023
Protected: Nephron KOL Call on Lab/Dx Industry Updates – Jan. 19th – REPLAY
January 17, 2023
Protected: Nephron Research JPM 2023 Conference Takeaways – REPLAY
January 13, 2023
TWIPE? This Week in Physician Enablement – San Fran Edition
January 5, 2023
Protected: CRC Screening KOL Call Post-ECLIPSE for EXAS/GH – REPLAY